Protocol of a randomised delayed-start double-blind placebo-controlled multi-centre trial for Levodopa in EArly Parkinson’s disease: the LEAP-study

Overview of attention for article published in BMC Neurology, November 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#48 of 1,636)
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 2 news outlets
blogs: 1 blog

twitter: 2 tweeters

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 78 Mendeley

Summary News Blogs Twitter Dimensions citations

So far, Dimensions has found 9 publications that cite this research output.

9

The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.

Morbus Parkinson und Restless-legs-Syndrom – ein unterschätztes Problem?

Article in Nervenheilkunde (October 2021)

Levodopa treatment in Parkinson's disease: earlier or later?

Article in Annals of Translational Medicine (September 2019)

Updates and advances in the treatment of Parkinson disease

Article in The Medical Journal of Australia (June 2019)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.